|
S.V. Nedogoda, A.S. Salasyuk, I.N. Barykina, V.O. Lutova, E.A. Popova, M.Yu. Frolov
Clinical and economic study of the use of ibrutinib in combination with venetoclax in patients with chronic lymphocytic leukemia
|
№6-7 / 2023
|
|
R.S. Pesotsky, V.F. Semiglazov, P.V. Krivorotko, T.T. Tabagua, K.Yu. Zernov, A.S. Emelyanov, T.Yu. Semiglazova, N. Amirov, V.V. Mortada, D.G. Ulrikh, V.E. Levchenko, K.Yu. Rychagov, K.Yu. Zirov, V.N. Evseev
Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
|
№6-7 / 2023
|
|
G.A. Khakimov, G.G. Khakimova, Kh.U. Musurmonov, Sh.G. Khakimova, G.P. Orifzhonova
Pelvic extrusion in patients with cervical cancer: clinical experience
|
№6-7 / 2023
|
|
O.O. Gordeeva, N.A. Meshcheryakova, A.A. Meshcheryakov
Lorlatinib in the treatment of ALK-positive non-small cell lung cancer
|
№6-7 / 2023
|
|
V.F. Semiglazov, A.V. Komyakhov, S.S. Ereshchenko, T.T. Tabagua, L.P. Gigolaeva, A.I. Tseluyko, A.P. Tergoeva, M.D. Kazantseva, N.S. Amirov, V.V. Mortada, R.S. Pesotsky, D.A. Enaldieva, L.F. Shaikhelislamova, K.S. Nikolaev, E.K. Zhiltsova, P.V. Krivorotko
Treatment of locally advanced (T2-3N0-1M0) and early (T1-2N0M0) HER2-positive breast cancer (clinical experience)
|
№6-7 / 2023
|
|
M.E. Abramov, T.E. Tikhomirova, O.E. Ryabishina, A.A. Rumyantsev, A.S. Tyulandina
Gastrointestinal stromal tumors: prospects for drug therapy of metastatic or inoperable forms
|
№6-7 / 2023
|
|
Ya.A. Yakimenko, V.V. Kutukov, V.V. Antonyan, M.A. Gaziev
Gastrointestinal toxicity during therapy with 5-fluorouracil
|
№6-7 / 2023
|
|
N.S. Besova
Conversion therapy for stage IV gastric cancer: a review of prognostic factors and patient selection criteria according to the literature data
|
№6-7 / 2023
|
|
L.A. Kramynin, L.V. Filatova, I.S. Zyuzgin, M.S. Motalkina, S.S. Elkhova, E.V. Dobrovolskaya, A.K. Kovyazin, T.Yu. Semiglazova
Primary mediastinal B-cell lymphoma: evolution and prospects for first-line therapy. Literature review
|
№6-7 / 2023
|
|
M.V. Gmoshinskaya, I.V. Aleshina
A new format for conducting classes in antenatal clinics with pregnant and lactating women in the modern world realities
|
№4-5 / 2023
|
|
O.A. Pustotina
Polycystic ovary syndrome phenotypes
|
№4-5 / 2023
|
|
I.Yu. Ilyina
Symptoms of menopausal disorders during perimenopause (review article)
|
№4-5 / 2023
|
Русский
